MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MEK inhibition affects STAT3 signaling and invasion in human melanoma cell lines

Published:2013-04-29 Issue:14 Volume:33 Page:1850-1861
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Vultur A,Villanueva J,Krepler C,Rajan G,Chen Q,Xiao M,Li L,Gimotty P A,Wilson M,Hayden J,Keeney F,Nathanson K L,Herlyn M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2013131.pdf

Reference57 articles.

1. Haass NK, Smalley KS, Herlyn M . The role of altered cell-cell communication in melanoma progression. J Mol Histol 2004; 35: 309–318.

2. Fecher LA, Cummings SD, Keefe MJ, Alani RM . Toward a molecular classification of melanoma. J Clin Oncol 2007; 25: 1606–1620.

3. Bollag G, Hirth P, Tsai J, Zhang J, Ibrahim PN, Cho H et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma. Nature 2010; 467: 596–599.

4. Lee JT, Li L, Brafford PA, van den Eijnden M, Halloran MB, Sproesser K et al. PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell Melanoma Res 2010; 23: 820–827.

5. Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011; 364: 2507–2516.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis;Frontiers in Cell and Developmental Biology;2023-04-26

2. Advancements in melanoma cancer metastasis models;Pigment Cell & Melanoma Research;2023-02-07

3. Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas;2023-01-21

4. From simplicity to complexity in current melanoma models;Experimental Dermatology;2022-10-05

5. Melanocyte stem cells in skin diseases and their potential in cell-based therapy;HISTOL HISTOPATHOL;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3